Table 1.
Total (N = 20) | ||
---|---|---|
Age | 65.75 ± 15 (range 44–97) | |
Male sex | 12 (60%) | |
Race | White or Caucasian | 15 (75%) |
Black or African American | 2 (10%) | |
Hispanic or Latino | 3 (15%) | |
Weight (kg) | 83.1 ± 22.1 | |
BMI | 26 ± 5.66 | |
Hypertension | 15 (75%) | |
Diabetes mellitus | 3 (15%) | |
Hyperlipidemia | 15 (75%) | |
Coronary artery disease | 4 (20%) | |
History of syncope | 7 (35%) | |
History of cerebrovascular accident | 3 (15%) | |
History of atrial fibrillation | 12 (60%) | |
Indications | ||
Management for known atrial fibrillation | 9 (45%) | |
Diagnosis of unexplained syncope | 8 (40%) | |
Cryptogenic stroke | 2 (10%) | |
Long term cardiac monitoring post atrial fibrillation ablation | 1 (5%) |